Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Non-Infectious Macular Edema Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...

For patients with diabetic macular edema (DME), intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection followed by a dexamethasone (DEX) intravitreal implant demonstrates ...

Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant ...

Macular edema is swelling in the retina that can cause blurry vision and vision loss. Macular edema can be treated with medications like NSAID eye drops, corticosteroids, or anti-VEGF drugs. Diabetes ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary cause of ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Sunir J. Garg, MD, shares his recent experience at the American Academy of Ophthalmology Annual Meeting in San Francisco and highlights two key takeaways. First, Dr Garg explores the ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

A recent study published in the journal Nature Medicine showed that targeting senescent cells in the retina can be a lasting disease-modifying treatment for diabetic macular edema (DME). The retina is ...